LARIMAR THERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $40.8M | $32.4M | $35.6M | $58.1M | $35.5M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $104.9M | $130.9M | $188.1M | $117.2M | $37.4M |
| Property, Plant & Equipment | $528.0K | $661.0K | $902.0K | $79.0K | $37.0K |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $105.5M | $131.6M | $189.1M | $117.5M | $38.1M |
| Liabilities | |||||
| Accounts Payable | $3.0M | $2.6M | $7.5M | $2.3M | $2.0M |
| Total Current Liabilities | $7.3M | $9.9M | $16.5M | $6.9M | $2.9M |
| Long-Term Debt | $20.0M | $3.2M | — | — | — |
| Total Liabilities | $27.3M | $9.9M | $20.0M | $13.1M | $2.9M |
| Stockholders' Equity | |||||
| Retained Earnings | $-289.6M | $-237.5M | $-179.7M | $-105.4M | $-68.9M |
| Total Stockholders' Equity | $78.2M | $121.7M | $169.1M | $104.4M | $-68.6M |